This website is for the U.S, for the other countries please refer to this link.
Sudomotor dysfunction in patients recovered from COVID-19 Anand Hinduja, Abdul Moutairou, Jean-Henri Calvet Article title: Sudomotor dysfunction in patients recovered from COVID-19. Neurophysiologie Clinique/Clinical Neurophysiology, Feb 2021. Dysautonomia has been reported in COVID-19 infection. Very recently an observational study, performed by Hinduja et al, from Aarti Clinic, Kharghar, Navi Mumbai, India, involved 50 patients who …
SUDOSCAN detects small fiber neuropathy in asymptomatic hepatitis C virus-related cirrhosis patients ES. Tharwa et al. Article title: Sudomotor Changes in Hepatitis C Virus Infection with or without Diabetes Mellitus: A Pilot Study in Egyptian Patients. Am. J. Trop. Med. Hyg., 00(0), 2020, pp. 1–5. In a study conducted by Tharwa et al from Menoufia …
Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
